Not checked for notices yet.
Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation
Catharina Bartmann, Sudha R. Janaki Raman, Jessica Flöter and 10 more
Cancer & Metabolism · 2018
Cited by papers we hold 1
- Ketogenic diet in the treatment of cancer – Where do we stand? · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.